|
BLOC1S2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
2.33840000030128E-07 |
| Normal-vs-Stage3 |
3.05311331771918E-14 |
| Normal-vs-Stage4 |
1.82550000005222E-07 |
| Stage1-vs-Stage2 |
2.044000E-01 |
| Stage1-vs-Stage3 |
9.755600E-01 |
| Stage1-vs-Stage4 |
3.034000E-02 |
| Stage2-vs-Stage3 |
2.895400E-01 |
| Stage2-vs-Stage4 |
4.800800E-01 |
| Stage3-vs-Stage4 |
4.122000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.2458000000023E-05 |
| Normal-vs-Asian |
7.85239984146813E-10 |
| Caucasian-vs-AfricanAmerican |
3.213400E-01 |
| Caucasian-vs-Asian |
4.013800E-01 |
| AfricanAmerican-vs-Asian |
6.273000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62669877568078E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
9.597200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
3.73590047786365E-13 |
| Normal-vs-Age(81-100Yrs) |
3.9754000000003E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.655000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.920000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.817800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.152200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.582400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.809800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.259600E-01 |
| Classical-VS-Follicular |
1.443780E-01 |
| Classical-VS-Other |
6.008400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.033400E-01 |
| Tall-VS-Other |
5.242200E-01 |
| Tall-VS-Normal |
3.45459999495645E-08 |
| Follicular-VS-Other |
9.306000E-01 |
| Follicular-VS-Normal |
3.97480000025041E-08 |
| Other-VS-Normal |
1.908260E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
2.32470000027796E-07 |
| N0-vs-N1 |
3.103800E-01 |
|
|
